Andrew is a senior member of Klick’s Consulting team, where he leads engagements across Klick’s healthcare clients. Previously, he was a Consultant with The Boston Consulting Group (BCG) healthcare practice and at IMS Health (now called IQVIA). Andrew also worked as a researcher in the fields of genomics and chemical-biology, where he developed new technologies for drug discovery and published numerous peer-reviewed articles in journals including Genome Research, Nature Chemical Biology, and Nature Biotechnology.
Andrew holds a PhD in Molecular Genetics from the University of Toronto as well as an MBA from the Ivey Business School and an Honours Bachelor of Science in Molecular Genetics and Molecular Biology from the University of Toronto.